下丘脑性性腺功能减退症女性的抗苗勒管激素与卵巢形态
荷兰学术医疗中心的回顾性队列研究纳入83名健康对照、159名下丘脑性性腺功能减退症(HH)女性和3640名多囊卵巢综合征(PCOS)女性,并按年龄1:2匹配出318名PCOS女性。HH组抗苗勒管激素(AMH)中位数3.8(<0.1-19.8),高于对照组1.9(<0.1-21.5)但低于PCOS组7.5(<0.1-81.0)(P < 0.001)。HH组中58人(36%)错误符合鹿特丹PCOS诊断标准。
要点
- HH女性AMH水平升高,中位数3.8(<0.1-19.8),对照组1.9(<0.1-21.5)(P < 0.001)。
- HH组58人(36%)错误符合鹿特丹PCOS标准(满足3项中2项)。
- 作者认为诊断PCOS前应测量促性腺激素和雌二醇。
核心结论
- 下丘脑性性腺功能减退症(HH)女性AMH水平升高。
- 作者假设HH女性AMH升高虽无卵泡计数增加,可能因存在直径小于2 mm、经阴道超声无法检测的较大窦卵泡池。
- 本研究强调诊断PCOS前测量促性腺激素和雌二醇的重要性。
研究设计与样本
- 荷兰学术医疗中心的回顾性队列研究。
- 纳入83名无排卵及月经周期紊乱的健康对照、159名HH女性和3640名PCOS女性。
- HH组与PCOS组按年龄1:2匹配,形成318名年龄匹配的PCOS女性第二组。
- 干预:无。
主要发现
- HH组AMH中位数3.8(<0.1-19.8),PCOS组7.5(<0.1-81.0),对照组1.9(<0.1-21.5)(P < 0.001)。
- HH组中58人(36%)错误符合鹿特丹PCOS诊断标准(满足3项中2项)。
关键数值与推荐
- 鹿特丹PCOS诊断标准需满足3项中2项。
- HH组AMH中位数3.8(<0.1-19.8),对照组1.9(<0.1-21.5),PCOS组7.5(<0.1-81.0),P < 0.001。
- HH组58人(36%)错误符合鹿特丹PCOS标准。
临床怎么用
- 作者强调诊断PCOS前应测量促性腺激素和雌二醇。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Different phenotypical features of women with hypothalamic hypogonadism (HH), also known as World Health Organization-1 anovulation, including ovarian morphology, have been scarcely described in large cohorts. Some studies have reported increased levels of anti-Müllerian hormone (AMH) in women with HH. OBJECTIVE: To assess whether women with HH, compared with healthy controls, have increased serum levels of AMH and what proportion of these women erroneously meet the Rotterdam Criteria for Polycystic Ovarian Syndrome (PCOS). DESIGN, SETTING AND PARTICIPANTS: Retrospective cohort study in a Dutch academic medical center including 83 women with neither anovulation nor menstrual cycle disorders (healthy controls), 159 women with HH and 3640 women with PCOS. Age matching was used between the HH and PCOS group (1:2 ratio) to create a second group consisting of 318 age-matched women with PCOS. INTERVENTION: None. MAIN OUTCOME MEASURES: AMH levels and ovarian morphology. RESULTS: Median AMH serum levels for the HH group were 3.8 (<0.1-19.8), compared with 7.5 (<0.1-81.0) in the PCOS group and 1.9 (<0.1-21.5) in the control group (P < 0.001). In the HH group, 58 (36%) erroneously met the Rotterdam Criteria for PCOS (meeting 2 of 3 criteria). CONCLUSIONS: AMH levels are increased in women with HH. We hypothesize that this increase, although there was no increase in follicle count, may be explained by the presence of a relatively large pool of antral follicles smaller than 2 mm in diameter, that are undetectable by transvaginal ultrasound. This study highlights the importance of measuring gonadotropins and estradiol before diagnosing a patient with PCOS.
引用
- Alemyar A, van der Kooi ALF, Laven JSE, et al. Anti-Müllerian Hormone and Ovarian Morphology in Women With Hypothalamic Hypogonadism. J Clin Endocrinol Metab. 2020. PMID: 32170295. doi:10.1210/clinem/dgaa116
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。